Generic Lamictal Buyers Defend Class Cert. At 3rd Circ.
Drug wholesalers have urged the Third Circuit to keep their class certification intact in a case alleging GlaxoSmithKline and Teva Pharmaceuticals' deal to delay generic versions of Lamictal harmed buyers of...To view the full article, register now.
Already a subscriber? Click here to view full article